Developability Assessment

Predicts the tendency of an antibody to self-associate into dimers or higher-order oligomers, a critical risk factor for immunogenicity and manufacturing failure. Computational tools analyze spatial aggregation propensity (SAP) and hydrophobic surface patches from 3D structures or sequences.

• SAP scoring: Identifies exposed hydrophobic hotspots on the CDR loops
• AC-SINS surrogate: Correlates computational indices with experimental gold nanoparticle assays
• Sequence-based predictors: Use machine learning trained on high-concentration stability data

Quantifies the conformational stability of the antibody variable domain. A higher melting temperature (Tm) and aggregation onset temperature (Tagg) correlate with long-term shelf-life and resistance to thermal stress during purification.

• Differential Scanning Fluorimetry (DSF) data used to train regression models
• Molecular Dynamics simulations calculate root-mean-square fluctuation (RMSF) per residue
• Fab vs. CH2/CH3 stability: Domain-specific unfolding profiles predict fragmentation patterns

Identifies sequence motifs susceptible to post-translational modifications that compromise potency and heterogeneity. Key liabilities include asparagine deamidation (NG, NS motifs), aspartate isomerization (DG, DS), and methionine oxidation.

• Solvent accessibility weighting: Buried residues are lower risk despite motif presence
• CDR proximity analysis: Liabilities in complementarity-determining regions are high-risk for antigen binding
• Forced degradation studies provide ground-truth labels for supervised classifiers

Predicts the maximum concentration achievable without precipitation or gel formation, essential for subcutaneous delivery formulations requiring >100 mg/mL concentrations. High viscosity impedes syringeability and manufacturability.

• Charge distribution asymmetry: Net dipole moments correlate with self-association at high concentrations
• Colloidal stability: Second virial coefficient (B22) computed from protein-protein interaction potentials
• Patch-patch interaction models: Identify electrostatic complementarity driving reversible clustering

Assesses non-specific hydrophobic interactions that drive rapid hepatic clearance and poor pharmacokinetic profiles. High hydrophobicity, particularly in CDR loops, correlates with fast in vivo clearance independent of FcRn-mediated recycling.

• Hydrophobic Interaction Chromatography (HIC) retention times serve as experimental benchmarks
• Fv surface hydrophobicity: Computed from 3D homology models using solvent-accessible surface area algorithms
• Poly-specificity assays: Flag candidates with promiscuous binding to unrelated antigens

Profiles the distribution of acidic and basic charge variants arising from deamidation, sialylation, and C-terminal lysine clipping. High heterogeneity complicates analytical characterization and raises regulatory comparability concerns.

• Calculated pI: Isoelectric point predicts chromatographic behavior during ion-exchange polishing
• Charge variant prediction: Machine learning models forecast acidic peak percentages from sequence features
• Glycation site prediction: Identifies lysine residues susceptible to non-enzymatic glucose adduction

A comprehensive computational screening cascade that aggregates predictions for aggregation propensity, thermal stability, and chemical liabilities to rank antibody candidates for manufacturing suitability. This process integrates multiple in silico tools to create a holistic risk score, often visualized as a spider plot or traffic-light system, enabling rapid triage of hundreds of candidates to identify those with the highest probability of progressing through Chemistry, Manufacturing, and Controls (CMC) development without costly reformulation.

The in silico identification of sequence motifs susceptible to chemical or enzymatic modifications that can compromise antibody stability and efficacy. Key liabilities include:

• Deamidation of asparagine-glycine (NG) motifs
• Oxidation of solvent-exposed methionine and tryptophan residues
• Isomerization of aspartic acid-glycine (DG) motifs
• Glycation of lysine residues
• N-terminal pyroglutamate formation Early PTM prediction prevents selecting candidates that would degrade during long-term storage or in vivo circulation.

A physics-based computational method for simulating the atomic movements and conformational flexibility of an antibody over microsecond to millisecond timescales. In the context of developability, MD simulations are used to:

• Assess paratope dynamics and binding interface stability
• Identify aggregation-prone regions (APRs) that become transiently exposed
• Calculate spatial aggregation propensity (SAP) scores
• Evaluate the conformational stability of the CDR-H3 loop
• Predict the impact of formulation conditions (pH, ionic strength) on colloidal stability

A computational framework that simultaneously optimizes an antibody sequence for multiple, often conflicting, properties to identify Pareto-optimal designs. A typical multi-objective optimization for developability balances:

• Affinity (maximize)
• Specificity (maximize cross-reactivity margin)
• Solubility (maximize, often predicted via CamSol or SOLpro)
• Immunogenicity (minimize T-cell epitope count)
• Thermal stability (maximize Tm)
• Expression titer (maximize for manufacturability) The output is a Pareto frontier of non-dominated solutions, allowing teams to make explicit trade-off decisions.

The computational estimation of an antibody's pH-dependent binding strength to the neonatal Fc receptor (FcRn), the primary mechanism governing the long circulatory half-life of IgG antibodies. FcRn binding must be strong at acidic endosomal pH (~6.0) to enable salvage from degradation, but weak at physiological pH (~7.4) to allow release back into circulation. Key developability considerations include:

• Predicting the impact of Fc mutations on pH-dependent binding
• Modeling the histidine protonation state at the CH2-CH3 interface
• Assessing how variable domain stability affects FcRn-mediated recycling
• Correlating predicted FcRn affinity with projected half-life extension

The use of machine learning to model the absorption, distribution, metabolism, and excretion (ADME) profile of an antibody therapeutic. Developability-focused PK prediction emphasizes:

• Half-life prediction from sequence and structural features
• Clearance rate estimation based on nonspecific binding and charge patches
• Tissue penetration modeling, particularly for solid tumor targets
• Target-mediated drug disposition (TMDD) simulation
• Predicting the impact of aggregation on accelerated clearance Integrating PK predictions early in candidate selection avoids advancing molecules with poor in vivo persistence.